{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:24:23Z","timestamp":1789424663191,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ijrobp.2004.02.004","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T16:30:36Z","timestamp":1093969836000},"page":"51-59","source":"Crossref","is-referenced-by-count":21,"title":["Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with 192ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25"],"prefix":"10.1016","volume":"60","author":[{"given":"Thomas","family":"Wahlgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Brandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"H\u00e4ggarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.02.004_BIB1","unstructured":"Cancer Incidence in Sweden 2000. Stockholm: National Board of Health and Welfare; 2002"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B","article-title":"International trends and patterns of prostate cancer incidence and mortality","volume":"85","author":"Hsing","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB3","doi-asserted-by":"crossref","unstructured":"Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781\u2013789","DOI":"10.1056\/NEJMoa012794"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB4","doi-asserted-by":"crossref","unstructured":"D'Amico AV, Whittington R, Kaplan I, et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4\u201320 ng\/mL. Int J Radiat Oncol Biol Phys 1997;37:1053\u20131058","DOI":"10.1016\/S0360-3016(96)00633-5"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB5","doi-asserted-by":"crossref","unstructured":"Fowler FJ Jr, Whittington R, Malkowicz SB, et al. Patient-reported complications and follow-up treatment after radical prostatectomy\u2014The National Medicare Experience: 1988\u20131990 (updated June 1993). Urology 1993;42:622\u2013629","DOI":"10.1016\/0090-4295(93)90524-E"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB6","doi-asserted-by":"crossref","unstructured":"Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790\u2013796","DOI":"10.1056\/NEJMoa021483"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB7","doi-asserted-by":"crossref","unstructured":"Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three Surveillance, Epidemiology and End Results areas. J Clin Oncol 1996;14:2258\u20132265","DOI":"10.1200\/JCO.1996.14.8.2258"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/107327480100800207","article-title":"The evolving role of prostate brachytherapy","volume":"8","author":"Beyer","year":"2001","journal-title":"Cancer Control"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB9","unstructured":"Bertermann H, Brix F. Technik der perinealen interstitiellen Iridium-192-Betstrahlung des Prostatakarzinoms. Verh Dtsch Ges Urol 1986;38:256\u2013258"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB10","doi-asserted-by":"crossref","unstructured":"Borghede G, Hedelin H, Holmang S, et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol 1997;44:245\u2013250","DOI":"10.1016\/S0167-8140(97)00122-9"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB11","doi-asserted-by":"crossref","unstructured":"Borghede G, Hedelin H, Holmang S, et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. Radiother Oncol 1997;44:237\u2013244","DOI":"10.1016\/S0167-8140(97)00121-7"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB12","doi-asserted-by":"crossref","unstructured":"Puthawala AA, Syed AM, Austin PA, et al. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy. Cancer 2001;92:2084\u20132094","DOI":"10.1002\/1097-0142(20011015)92:8<2084::AID-CNCR1549>3.0.CO;2-C"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB13","doi-asserted-by":"crossref","unstructured":"Galalae RM, Kovacs G, Schultze J, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:81\u201390","DOI":"10.1016\/S0360-3016(01)01758-8"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00066-002-0920-0","article-title":"High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy","volume":"178","author":"Lennernas","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-5347(05)67818-4","article-title":"Quality of life outcomes after brachytherapy for early stage prostate cancer","volume":"163","author":"Brandeis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB16","doi-asserted-by":"crossref","unstructured":"Wei JT, Dunn RL, Dandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557\u2013566","DOI":"10.1200\/JCO.20.2.557"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB17","first-page":"147","article-title":"A prospective analysis of patient-reported quality of life after prostate brachytherapy","volume":"18","author":"Lee","year":"2000","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB18","doi-asserted-by":"crossref","unstructured":"Joly F, Brune D, Couette B, et al. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer. Ann Oncol 1998;9:751\u2013757","DOI":"10.1023\/A:1008276632623"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB19","doi-asserted-by":"crossref","unstructured":"Egawa S, Kattan MW, Subong EN, et al. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol 2001;31:541\u2013547","DOI":"10.1093\/jjco\/hye115"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB20","first-page":"1035","article-title":"Consensus statement","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB21","doi-asserted-by":"crossref","unstructured":"Partin AW, Shimura S, Irie A, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445\u20131451","DOI":"10.1001\/jama.1997.03540420041027"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB22","doi-asserted-by":"crossref","unstructured":"Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001;58:843\u2013848","DOI":"10.1016\/S0090-4295(01)01441-8"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB23","doi-asserted-by":"crossref","unstructured":"Bolla M, Gonzalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295\u2013300","DOI":"10.1056\/NEJM199707313370502"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB24","doi-asserted-by":"crossref","unstructured":"Arterbery VE, Wallner K, Roy J, Fuks Z. Short-term morbidity from CT-planned transperineal I-125 prostate implants. Int J Radiat Oncol Biol Phys 1993;25:661\u2013667","DOI":"10.1016\/0360-3016(93)90013-L"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB25","doi-asserted-by":"crossref","unstructured":"Padula GD, Zelefsky MJ, Venkatraman ES, et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:439\u2013443","DOI":"10.1016\/S0360-3016(01)02604-9"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB26","doi-asserted-by":"crossref","unstructured":"Michelson H, Bolund L, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30\u2014Reference values from a large sample of Swedish population. Acta Oncol 2000;39:477\u2013484","DOI":"10.1080\/028418600750013384"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB27","doi-asserted-by":"crossref","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365\u2013376","DOI":"10.1093\/jnci\/85.5.365"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB28","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organization for Research and Treatment of Cancer; 2001"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB29","doi-asserted-by":"crossref","unstructured":"Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK, for the European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: Guidelines for developing questionnaire modules. Qual Life Res 1993;2:287\u2013295","DOI":"10.1007\/BF00434800"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB30","unstructured":"Aaronson NK, Van Andel G, for the EORTC Genito Urinary Tract Cancer Group. An international field of the reliability and validity of the QLQ-C30 and a disease-specific questionnaire module (QLQ-PR25) for assessing quality of life of patients with prostate cancer. European Organization for Research and Treatment of Cancer study protocol (15011), Brussels 2002"},{"key":"10.1016\/j.ijrobp.2004.02.004_BIB31","doi-asserted-by":"crossref","unstructured":"Merrick GS, Butler WM, Wallner KE, et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002;54:1055\u20131062","DOI":"10.1016\/S0360-3016(02)03031-6"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604002445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604002445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T02:56:49Z","timestamp":1549249009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604002445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0360301604002445"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.02.004","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}